Skip to main content
. 2019 Mar 25;10(3):312–323. doi: 10.1177/2192568219837923

Figure 4.

Figure 4.

VAS baseline scores compared to 12-month follow-up (−3.68 [95% CI: −4.26 to −3.10]; heterogeneity: I2 = 98.1%, P < .001).